About this trial
In this study, the investigators compared the improvement of immune function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
Splenomegaly with secondary hypersplenism
gastroesophageal variceal bleeding
Informed consent to participate in the study
Disqualifiers
Hepatocellular carcinoma or any other malignancy,
Child-Pugh grade C
Recent peptic ulcer disease
History of Hemorrhagic stroke
Trial design
Single group
Treatments tested in this trial
Laparoscopic splenectomy and azygoportal disconnection
Procedure/SurgeryLaparoscopic splenectomy and azygoportal disconnection is performed by the same surgical team.
Treatment groups
Trial outcomes
Primary outcomes
The immune function CD4+ at 3 months after surgery
The level of the immune function CD4+ at 3 months after surgery
The immune function CD4+ at 6 months after surgery
The level of the immune function CD4+ at 6 months after surgery
The immune function CD4+ at 12 months after surgery
The level of the immune function CD4+ at 12 months after surgery
The immune function CD4+ at 24 months after surgery
The level of the immune function CD4+ at 24 months after surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.